Suppr超能文献

一种多巴胺 D 受体四级结构选择性拮抗剂失稳的分子基础。

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D Receptor Quaternary Organization.

机构信息

Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, UK.

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.

出版信息

Sci Rep. 2017 May 18;7(1):2134. doi: 10.1038/s41598-017-02249-3.

Abstract

The dopamine D receptor (DR) is a molecular target for both first-generation and several recently-developed antipsychotic agents. Following stable expression of this mEGFP-tagged receptor, Spatial Intensity Distribution Analysis indicated that a substantial proportion of the receptor was present within dimeric/oligomeric complexes and that increased expression levels of the receptor favored a greater dimer to monomer ratio. Addition of the antipsychotics, spiperone or haloperidol, resulted in re-organization of DR quaternary structure to promote monomerization. This action was dependent on ligand concentration and reversed upon drug washout. By contrast, a number of other antagonists with high affinity at the DR, did not alter the dimer/monomer ratio. Molecular dynamics simulations following docking of each of the ligands into a model of the DR derived from the available atomic level structure, and comparisons to the receptor in the absence of ligand, were undertaken. They showed that, in contrast to the other antagonists, spiperone and haloperidol respectively increased the atomic distance between reference α carbon atoms of transmembrane domains IV and V and I and II, both of which provide key interfaces for DR dimerization. These results offer a molecular explanation for the distinctive ability of spiperone and haloperidol to disrupt DR dimerization.

摘要

多巴胺 D 受体 (DR) 是第一代和几种最近开发的抗精神病药物的分子靶标。在稳定表达这种 mEGFP 标记的受体后,空间强度分布分析表明,相当一部分受体存在于二聚体/寡聚体复合物中,并且受体的表达水平增加有利于更大的二聚体与单体的比例。加入抗精神病药,螺哌隆或氟哌啶醇,导致 DR 四级结构重新组织以促进单体化。这种作用依赖于配体浓度,并在药物洗脱后逆转。相比之下,其他一些在 DR 上具有高亲和力的拮抗剂不会改变二聚体/单体的比例。在将每种配体对接入可从现有原子水平结构获得的 DR 模型之后进行分子动力学模拟,并与无配体时的受体进行比较,表明与其他拮抗剂相反,螺哌隆和氟哌啶醇分别增加了跨膜结构域 IV 和 V 以及 I 和 II 的参考α碳原子之间的原子距离,这两者都为 DR 二聚化提供了关键界面。这些结果为螺哌隆和氟哌啶醇破坏 DR 二聚化的独特能力提供了分子解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc52/5437050/bbadfd63337a/41598_2017_2249_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验